The drug delivery market in the U.S is on the threshold of a landmark innovation. The hospital- based treatment of diabetes will remain totally supported by traditional infusion products.
February 16, 2006 (Press Release) --
The drug delivery market in the U.S is on the threshold of a landmark innovation. The hospital- based treatment of diabetes will remain totally supported by traditional infusion products. Indeed, the imminent arrival of implantable insulin and the disposable insulin pumps are enough to bring about a world of change in this fully developed sector.
The non-infusion drug delivery technologies on the other hand are on the verge of a major growth, as they will make daily insulin administration less difficult and more effective. To expand the number of compounds that can be delivered via the skin, researchers are developing novel methods that shall benefit the patients enabling them a cost effective treatment.
In order to make a wearable, lightweight drug delivery system probable, the Transdermal Insulin Drug Delivery (TDD) System Dermisonics’ research is totally based upon the design of a unique hardware platform. The flexible patch design is essential to the new two-part (TDD) Transdermal Drug Delivery System and is known as the Medi-Cap.
The latest market research report by RNCOS titled “Insulin Delivery System – The State of the Science and Market Opportunities”, discusses about the recent discoveries in the field of insulin delivery systems, MEMS (Micro Electro Mechanical Systems) along with its uses, its scientific characteristics and the effects that Bio-IT technology has on Insulin Drug delivery System.
The various aspects of the insulin delivery system market are discussed here in detail. The report forecasts South and Central America with a 34% growth, to take the lead in this development with Europe, Middle-east and South East Asia following at the fag end, with a contribution of 8% each.
An in depth analysis about the significant developments in the drug delivery market exploring the emerging trends of the various drug delivery methods that are presently being employed by the drug manufacturers has been covered.
The report by RNCOS evaluates the market viability of this landmark medical innovation discussing and investigating the various kinds of drug delivery techniques. It gives details of the different brands of drug delivery systems along with their significant applications.
To purchase your copy: http://www.rncos.com/Report/Biotech06.htm
For more information about the report please visit www.rncos.com
The non-infusion drug delivery technologies on the other hand are on the verge of a major growth, as they will make daily insulin administration less difficult and more effective. To expand the number of compounds that can be delivered via the skin, researchers are developing novel methods that shall benefit the patients enabling them a cost effective treatment.
In order to make a wearable, lightweight drug delivery system probable, the Transdermal Insulin Drug Delivery (TDD) System Dermisonics’ research is totally based upon the design of a unique hardware platform. The flexible patch design is essential to the new two-part (TDD) Transdermal Drug Delivery System and is known as the Medi-Cap.
The latest market research report by RNCOS titled “Insulin Delivery System – The State of the Science and Market Opportunities”, discusses about the recent discoveries in the field of insulin delivery systems, MEMS (Micro Electro Mechanical Systems) along with its uses, its scientific characteristics and the effects that Bio-IT technology has on Insulin Drug delivery System.
The various aspects of the insulin delivery system market are discussed here in detail. The report forecasts South and Central America with a 34% growth, to take the lead in this development with Europe, Middle-east and South East Asia following at the fag end, with a contribution of 8% each.
An in depth analysis about the significant developments in the drug delivery market exploring the emerging trends of the various drug delivery methods that are presently being employed by the drug manufacturers has been covered.
The report by RNCOS evaluates the market viability of this landmark medical innovation discussing and investigating the various kinds of drug delivery techniques. It gives details of the different brands of drug delivery systems along with their significant applications.
To purchase your copy: http://www.rncos.com/Report/Biotech06.htm
For more information about the report please visit www.rncos.com
Email
Print
SPAM
